14
Participants
Start Date
April 15, 2019
Primary Completion Date
November 30, 2023
Study Completion Date
April 30, 2024
Sintilimab
"Sintilimab 200mg IV, every 3 weeks, until progressive disease (PD), intolerable toxicity, or at a maximum of 24 months.~Before enrollment, patient should undergo radiation no less than dose 30Gy( 6 Gy × 5, or other ), or the planned dose could reach 30 Gy. Sintilimab shall be started no later than 3 weeks after radiation. Radiotherapy can be performed on the same day as sintilimab."
Department of Respiratory Medicine, Peking Union Medical College Hospita, Beijing
Peking Union Medical College Hospital
OTHER